Navigation Links
Hybridoma Development,,, from QED Bioscience Inc.

ProductsHybridoma Development, from QED Bioscience Inc.
Company QED Bioscience Inc.
Item Hybridoma Development
Price 
Description QED Bioscience has over 23 years of experience in the development of hybridoma cells lines. We have made antibodies to large and small peptides, proteins, haptens, carbohydrates, bacterial and viral antigens, and plasmid DNA-encoded antigens. We understand and appreciate that every antigen is unique, so our hybridoma development programs are never "cookbook". We will tailor a program to your needs after we discuss important features of your antigens and the antibodies you require.

Features and Benefits:

  • Typical time frame for completion is 5-6 months.
  • Project tailored to the clients specific antibody needs.
  • Our programs are "modular", so you can choose how large or small you want each phase of your program to be.
  • Supernatant samples available to the client for testing in their system for subcloning selection.
  • Antibody is produced from 5 clones selected by the client; antibody from additional clones can be produced for a nominal cost.
  • All materials are the property of the client and are maintained until directed otherwise by the client.
  • Development is set up in phases. Billing is at the beginning of each phase, so if the project does not proceed to the subsequent phase, you are not billed.
PHASE I: IMMUNIZATION

1. Immunization of 5 Balb/c mice.
2. Initial rest period of 8 weeks to optimize for high titer IgG responses.
2. Test bleeds are evaluated by ELISA; bleeds are available to the client for testing.
3. The animals with the highest titers for selected for fusion.

Estimated completion time: 10-14 weeks ($1,845.00)

PHASE II: FUSION

1. Spleen cells from selected animals are fused with two different myeloma cell lines.
2. Remaining fusion cocktail is frozen for future use, if necessary.

Estimated completion time: 2-3 weeks ($3,690.00)

PHASE III: ANALYSIS

1. Antibody-positive parental hybridomas and subclones are evaluated by ELISA.
2. Supernatant fluid samples are available to the client for evaluation in their systems.
Up to 25 antibody-positive cultures will be carried through the subcloning and analysis phase.
5 clones may be selected for Antibody Production; antibody may be produced from additional clones for a nominal charge.

Estimated completion time: 6-8 weeks ($2,240.00)

PHASE IV: ANTIBODY PRODUCTION

1. Antibody is produced either in ascites (5 mice per clone) or in vitro (150 ml per clone).
2. Our proprietary in vitro medium produces 5-25 fold greater yields of antibody than conventional media.
3. All antibody production is done to cGMP standards.

Estimated completion time: 3-4 weeks ($1,150.00)

Total Estimated Completion Time: 5-6 months ($8,925.00)

GMP Ascites Production

QED offers complete programs for ascites production, from small R&D scale to pilot lot production to large-scale production. We are a USDA-registered research facility, and we comply with all federal guidelines for care and use of laboratory animals.

You may provide your hybridoma cell lines to QED either frozen or in culture. We will advise you on how many cells to send and how to ship your cells to us. Approximately one week is needed to prepare cells from frozen stocks for injection, and there is an additional charge for this service (see below).

Nude and SCID mice are available for ascites production for non-murine hybridoma cell lines.

Hybridomas are injected into pristane-primed mice, then mice are monitored daily for ascites development and general condition. Ascites collection begins when accumulation of ascites becomes evident and continues until final harvests are performed. If you choose, you can receive unpurified, defibrinated ascites, or QED will purify ascites for you (s

Info QED Bioscience Inc.QED Bioscience Inc.
QED Bioscience Inc.
11021 Via Frontera #203
San Diego, CA 92127
Customer Service: (800) 929-2114
Fax Number: (858) 592-1509
Web Site: http://www.qedbio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mouse Anti-Xenopus laevis Xenopus nuclear factor Antibody, Unconjugated from Developmental Studies Hybridoma Bank
2. Hybridoma Storage from AbD Serotec
3. Mouse Anti-Drosophila Quail Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
4. Mouse Anti-Drosophila Yan Drosophila protein Antibody, Unconjugated from Developmental Studies Hybridoma Bank
5. Mouse Anti-Xenopus laevis Xenopus nuclear factor, xnf7 Antibody, Unconjugated from Developmental Studies Hybridoma Bank
6. Mouse Anti-Quail cell marker Antibody, Unconjugated from Developmental Studies Hybridoma Bank
7. Mouse Anti-Human VCAM-1 Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
8. Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
9. Mouse Anti-Drosophila fasciclin III Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
10. Hybridoma Development from Covance Research Products, Inc
11. Mouse Anti-Human huntingtin Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
A collection of 42 spots with normal tissues from different organs of C57 mice, rat and human....
... which is based on a new flow-through technology, ... in situ hybridization of tissues on microscope slide ... study of gene expression, in situ hybridization (ISH) ... can be used to validate and confirm results ...
... voice-coil scanning and positioning system is ... have to be positioned or scanned ... It provides superior responsiveness compared to ... mechanics (X or XY stage) are ...
... Analyst Software has been optimized for the ... allow the software to quickly and accurately ... well of an ELISA plate or each ... Software has been customized to incorporate standard ...
Biology Products:
(Date:4/2/2015)... -- Fingerprint Cards (FPC) has received an ... distributor World Peace Industrial Group (WPI), part of WPG ... major part of the shipments will take place during ... manufacturers in China . The order ... revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... and Voice Biometrics - Global Strategic Business Report" report to ... Face and Voice Biometrics in US$ Thousands by the following Segments: ... for the US, Canada , Japan ... , Middle East & Africa ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... 2010 New evidence that genetics play a significant role ... can do everything right and still give birth too soon. ... for Maternal-Fetal Medicine (SMFM) meeting -- The Pregnancy Meeting -- ... fetus can make them susceptible to an inflammatory response that ...
... Himalayan mountains are thinning is not disputed. However, few ... causes. Lawrence Berkeley National Laboratory scientist Surabi Menon set ... blamed culpritgreenhouse gases, such as carbon dioxidefrom other particles ... Menon and her collaborators found that airborne black carbon ...
... could predict which patients with the lung-scarring disease known as ... an indicator that could one day influence their treatment, according ... Their findings, published online last week in PLoS One ... tissue, suggesting that IPF is in fact an immunologic disease. ...
Cached Biology News:New research shows genes of pregnant women and their fetuses can increase the risk of preterm labor 2Black carbon a significant factor in melting of Himalayan glaciers 2Black carbon a significant factor in melting of Himalayan glaciers 3Test could predict which idiopathic pulmonary fibrosis patients will become severely ill 2
(Date:4/21/2015)... -- Immune Pharmaceuticals Inc., or "Immune" (NASDAQ: IMNP ... Rene-Pierre Azria as a Director and the ... on strategic and financial transactions. Mr. Azria will also ... Committee and the Corporate Governance and Nomination Committee. ... a long-time interest in Life Sciences and in particular ...
(Date:4/21/2015)... San Bruno, CA (PRWEB) April 21, 2015 ... Expert CRO, will sponsor and exhibit at the ACRP ... in Salt Lake City, Utah. The Association of Clinical ... largest annual clinical research conference solely focused on the ... through membership, training and development, and widely recognized industry ...
(Date:4/21/2015)... April 21, 2015 Whether it’s used for ... or bolted to a Kessler CineDrive in a ... the beach, the TS3-H is designed to help any shooter ... brand-new state-of-the-art 5MP sensor, the TS5-H offers the same convenient ... imaging characteristics. , According to Tom Boldt for Fastec, ...
(Date:4/20/2015)... Orthobiologics are substances that are ... orthobiologics market is a rewarding market, which represents a ... orthobiologics market report defines and segments the concerned market ... market was valued at $5,712.4 million in 2014, and ... a CAGR of 6.7% from 2014 to 2019. ...
Breaking Biology Technology:Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 2Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 3Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 4PRC Clinical Sponsors The ACRP 2015 Global Conference And Meets Biotech Companies in the Salt Lake City Area. 2Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 2Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 3Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 2Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 3